Flosonics’ FloPatch expands to East Coast

Flosonics Medical, the leader in wearable ultrasound for critical care, recently announced that The Mount Sinai Hospital has adopted FloPatch, the first wireless Doppler ultrasound device, in its surgical and transplant intensive care units. This milestone marks the company’s first East Coast deployment, expanding its U.S. footprint and reinforcing growing demand for real-time, individualized fluid management in ICUs.

FloPatch is an FDA-cleared, non-invasive wearable device that enables ICU clinicians to perform rapid, repeatable hemodynamic assessments to guide intravenous (IV) fluid management, a critical intervention in post-surgical care.

Flosonics Medical is an OBIO® member, an alumnus of our BDSP™, CAAP®, EAHN™, HealthMINT™, LSCTC Centre of Excellence and WiHI programs, and presented at the OBIO® Investment Summit.